Scarica l'app Stockscreener
193.76
3.17%
5.95
Dopo l'orario di chiusura:
195.00
1.24
+0.64%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$187.81
Aprire:
$188.925
Volume 24 ore:
1.72M
Relative Volume:
0.94
Capitalizzazione di mercato:
$29.32B
Reddito:
$4.39B
Utile/perdita netta:
$853.00M
Rapporto P/E:
35.17
EPS:
5.5097
Flusso di cassa netto:
$556.00M
1 W Prestazione:
+2.69%
1M Prestazione:
+21.08%
6M Prestazione:
+37.35%
1 anno Prestazione:
+98.85%
Intervallo 1D:
$188.48
$195.97
Intervallo di 1 settimana:
$184.66
$196.66
Portata 52W:
$88.00
$196.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
193.76 | 28.42B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
524.71 | 189.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
195.98 | 135.02B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
558.60 | 43.83B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
281.85 | 39.30B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.59 | 36.45B | 7.23B | 1.41B | 1.09B | 4.979 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina Inc (ILMN) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 72/100 - GuruFocus
Illumina sets July 30 call on second-quarter 2026 results - Stock Titan
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - marketscreener.com
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer - Morgan County Citizen
Genomics Giant Illumina Taps Veteran Life Sciences Lawyer - Law.com
Illumina (ILMN) Is Up 6.87% in One Week: What You Should Know - Yahoo Finance
Illumina stock steadies as investors weigh core sequencing demand and regulatory overhang - Ad-hoc-news.de
Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat (NASDAQ:ILMN) - Seeking Alpha
Illumina Stock Gains 43.7% in 2026: What's Powering the Rally? - TradingView
Illumina, Inc. Announces Management Appointments - marketscreener.com
Illumina Appoints Michael Sullivan and Julie Coletti to Executive Leadership Team - citybiz
Illumina appoints new commercial and legal officers - Investing.com
Illumina Inc. focuses on genomics growth as a leading Nasdaq-listed life sciences company - Ad-hoc-news.de
Align's Julie Coletti to Leave as Chief Legal and Regulatory Officer for Illumina - TradingView
Illumina (ILMN) Stock May Be 27% Undervalued Following Strong Q1 Results - Yahoo Finance
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Illumina (ILMN) Jumps On Earnings And Guidance As Valuation Questions Remain - Yahoo Finance
Illumina (ILMN) Is Up 9.1% After Raising EPS Outlook On Revenue Beat Has The Bull Case Changed? - Yahoo Finance
Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform - BioSpace
Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Illumina (ILMN) Lifts Full Year EPS Outlook After Revenue Beat - Yahoo Finance
David P. King elected to Illumina's Board of Directors - AOL.com
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc focuses on sequencing platform innovation as investors weigh long-term growth prospects - Ad-hoc-news.de
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN) - Yahoo Finance
Illumina stock stays tied to its sequencing business. Investors watch the next filing. - Ad-hoc-news.de
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Looks To Duck DNA Rival's Renewed Antitrust Case - Law360
Weekly Recap: Axelios challenges Illumina and Guggenheim lifts ILMN target to $200 - TradingView
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Downsides Amidst 33.82% ROE - DirectorsTalk Interviews
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGR - GlobeNewswire Inc.
iSeq 100 System from Illumina Inc.compact benchtop sequencer targets cost-conscious US labs - Ad-hoc-news.de
Is Illumina (ILMN) Quietly Recasting Its Clinical Genomics Strategy With Eli Lilly’s R&D Chief on Board? - simplywall.st
Illumina Inc. focuses on sequencing technology leadership as investors watch long-term growth driver - Ad-hoc-news.de
Illumina SVP Jakob Wedel Christensen sells $97,328 in stock - Investing.com
Illumina Inc. focuses on sequencing technology as investors assess long-term growth - Ad-hoc-news.de
Should You Continue to Hold ILMN Stock in Your Portfolio? - TradingView
Price to sales forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Price to book forward of Illumina, Inc. – NASDAQ:ILMN - TradingView
Form 4 Illumina Inc For: 2 July By Investing.com - Investing.com Canada
Illumina (ILMN) director takes 2026 board fees entirely in stock - Stock Titan
[Form 4] ILLUMINA, INC. Insider Trading Activity - Stock Titan
ILMNIllumina Inc Volatility & Greeks - Finviz
Loomis Sayles Growth Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc (ILMN) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Illumina (ILMN) Gets Bernstein’s Market Perform Rating Amid NovaSeq X Recovery - Insider Monkey
Illumina stock hits 52-week high at 182.98 USD - Investing.com
Illumina stock hits 52-week high at 182.98 USD By Investing.com - Investing.com South Africa
Illumina Inc. focuses on sequencing and clinical genomics as investors watch long term growth - AD HOC NEWS
Piper Sandler raises Illumina stock price target on clinical strength - Investing.com
Why Illumina (ILMN) Stock Is Down Today - Yahoo Finance
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.13%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):